Abad Cybele L, Lansang Mary Ann D, Cordero Cynthia P, Viray Ethel Dominique E, Tiangco Beatrice J, Bello Jia An G, Francisco Jan Jorge M, Buensalido Marja B, Tayzon Maria Fe R, Henson Karl Evans R, Berba Regina P, Pacheco Elizabeth Paz-, Saniel Mediadora C
Department of Medicine, Section of Infectious Diseases, The Medical City, Pasig City, Philippines.
Department of Clinical Epidemiology, College of Medicine, University of the Philippines-Manila, Philippines.
Clin Epidemiol Glob Health. 2021 Apr-Jun;10:100695. doi: 10.1016/j.cegh.2020.100695. Epub 2021 Jan 17.
Our healthcare institution was one of the first to see SARS CoV-2 cases in the country. We describe the early COVID-19 experience of a private hospital in the Philippines and discuss the healthcare system response in the setting of surge capacity.
We reviewed the medical records of adult COVID-19 hospitalized patients admitted in March 2020. We reported their demographic and clinical characteristics using descriptive statistics.
Of 40 patients admitted, 23 (57.5%) were male and 19 (47.5%) were aged <60 years. Most (n = 27, 67.5%) had moderate-risk, 9 (22.5%) had high-risk, and 4 (10%) had low-risk COVID-19. SARS-CoV-2 testing took 5.5 (range 1-10) days. Overall mortality rate was 6/40 (15.0%). Clinical cure was documented in all low-risk patients, 25 (92.6%) moderate-risk patients, and only 1 (11.1%) high-risk patient. In response to the surge, the hospital rapidly introduced one-way traffic systems, dedicated screening, triage and Emergency Department areas for COVID-19, a clinical pathway, engineering controls, patient cohorting, and strict infection prevention and control measures.
Majority of patients recovered from COVID-19. Older age and high-risk pneumonia were associated with poor outcomes. Adaptations to hospital structure and staff were quickly made in response to surge capacity, although our response was hampered by prolonged time to COVID-19 confirmation. Our study underscores the urgent need for rapid adaptive response by the healthcare system to address the surge of cases.
我们的医疗机构是该国最早发现严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病例的机构之一。我们描述了菲律宾一家私立医院早期应对2019冠状病毒病(COVID-19)的经历,并讨论了在激增容量情况下的医疗系统应对措施。
我们回顾了2020年3月收治的成年COVID-19住院患者的病历。我们使用描述性统计方法报告了他们的人口统计学和临床特征。
在40名入院患者中,23名(57.5%)为男性,19名(47.5%)年龄<60岁。大多数(n = 27,67.5%)患有中度风险的COVID-19,9名(22.5%)患有高风险,4名(10%)患有低风险。SARS-CoV-2检测耗时5.5天(范围1 - 10天)。总死亡率为6/40(15.0%)。所有低风险患者、25名(92.6%)中度风险患者和仅1名(11.1%)高风险患者有临床治愈记录。为应对病例激增,医院迅速引入了单向交通系统、专门的COVID-19筛查、分诊和急诊科区域、临床路径、工程控制、患者分组以及严格的感染预防和控制措施。
大多数COVID-19患者康复。高龄和高风险肺炎与不良预后相关。尽管我们的应对因COVID-19确诊时间延长而受阻,但为应对激增容量,医院结构和工作人员迅速做出了调整。我们的研究强调了医疗系统迅速做出适应性反应以应对病例激增的迫切需求。